• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[小叶性乳腺癌的临床、形态学特征及治疗]

[Clinical and morphological features and treatment for lobular breast cancer].

作者信息

Tabagua T T, Semiglazov V V, Bus'ko E A, Semiglazova T Iu, Voroshnikov V V

出版信息

Vopr Onkol. 2013;59(3):386-9.

PMID:23909043
Abstract

The study presents data on the treatment of lobular breast cancer. On the basis of the studied morphological and molecular-biological characteristics there were substantiated types of treatment that improved the survival of patients with invasive lobular carcinoma. It was showed the efficacy of systemic treatment for lobular breast cancer and also studied long-term outcomes of lobular breast cancer depending on the morphological and biological features.

摘要

该研究展示了小叶型乳腺癌的治疗数据。基于所研究的形态学和分子生物学特征,证实了可提高浸润性小叶癌患者生存率的治疗类型。研究显示了小叶型乳腺癌全身治疗的疗效,并根据形态学和生物学特征研究了小叶型乳腺癌的长期预后。

相似文献

1
[Clinical and morphological features and treatment for lobular breast cancer].[小叶性乳腺癌的临床、形态学特征及治疗]
Vopr Onkol. 2013;59(3):386-9.
2
Breast cancer in very young women.年轻女性乳腺癌。
Eur J Surg Oncol. 2011 Dec;37(12):1030-7. doi: 10.1016/j.ejso.2011.08.133. Epub 2011 Sep 21.
3
Distinctive biology of pleomorphic lobular carcinoma of the breast.乳腺多形性小叶癌的独特生物学特性。
J Surg Oncol. 2005 May 1;90(2):47-50. doi: 10.1002/jso.20246.
4
Isolated loss of hormonal receptors in leptomeningeal metastasis from estrogen receptor- and progesterone receptor-positive lobular breast cancer.雌激素受体和孕激素受体阳性的小叶性乳腺癌软脑膜转移中激素受体的孤立性丧失
J Clin Oncol. 2010 May 1;28(13):e200-2. doi: 10.1200/JCO.2009.25.3518. Epub 2010 Feb 1.
5
Docetaxel followed by fluorouracil/epirubicin/cyclophosphamide as neoadjuvant chemotherapy for patients with primary breast cancer.多西他赛序贯氟尿嘧啶/表柔比星/环磷酰胺新辅助化疗治疗原发性乳腺癌患者。
Jpn J Clin Oncol. 2011 Jul;41(7):867-75. doi: 10.1093/jjco/hyr081.
6
Randomized phase 3 trial of fluorouracil, epirubicin, and cyclophosphamide alone or followed by Paclitaxel for early breast cancer.氟尿嘧啶、表柔比星和环磷酰胺单药或序贯紫杉醇用于早期乳腺癌的随机3期试验。
J Natl Cancer Inst. 2008 Jun 4;100(11):805-14. doi: 10.1093/jnci/djn151. Epub 2008 May 27.
7
Association between c-myc amplification and pathological complete response to neoadjuvant chemotherapy in breast cancer.c-myc 扩增与乳腺癌新辅助化疗病理完全缓解的相关性。
Eur J Cancer. 2011 Aug;47(12):1779-88. doi: 10.1016/j.ejca.2011.06.017. Epub 2011 Jul 7.
8
Does neoadjuvant/adjuvant chemotherapy change the natural history of classic invasive lobular carcinoma?新辅助/辅助化疗会改变经典浸润性小叶癌的自然病程吗?
J Clin Oncol. 2005 Sep 20;23(27):6796; author reply 6796-7. doi: 10.1200/JCO.2005.02.1402.
9
Molecular class as a predictor of locoregional and distant recurrence in the neoadjuvant setting for breast cancer.分子亚型作为新辅助治疗乳腺癌局部和远处复发的预测指标。
Oncology. 2011;80(5-6):341-9. doi: 10.1159/000330203. Epub 2011 Jul 26.
10
Letrozole plus GnRH analogue as preoperative and adjuvant therapy in premenopausal women with ER positive locally advanced breast cancer.来曲唑联合 GnRH 类似物作为 ER 阳性局部晚期乳腺癌绝经前妇女的术前和辅助治疗。
Breast Cancer Res Treat. 2011 Apr;126(2):431-41. doi: 10.1007/s10549-010-1340-y. Epub 2011 Jan 8.